XML 14 R5.htm IDEA: XBRL DOCUMENT v3.22.1
Condensed Consolidated Statements of Stockholders' Equity (Unaudited) - USD ($)
Preferred Stock [Member]
Common Stock [Member]
Additional Paid-in Capital [Member]
Retained Earnings [Member]
Total Harrow Health, Inc. Stockholders' Equity [Member]
Noncontrolling Interest [Member]
Total
Beginning balance, value at Dec. 31, 2020 $ 26,000 $ 104,557,000 $ (77,400,000) $ 27,183,000 $ (355,000) $ 26,828,000
Beginning Balance, shares at Dec. 31, 2020 25,749,875          
Exercise of employee options     27,000 27,000 27,000
Exercise of employee options, shares   11,301          
Vesting of RSUs    
Vesting of RSUs, shares   230,000          
Shares withheld related to net share settlement of equity awards (57,000) (57,000) (57,000)
Shares withheld related to net share settlement of equity awards, shares   (7,500)          
Stock-based compensation expense 855,000 855,000 855,000
Net loss 217,000 217,000 217,000
Ending balance, value at Mar. 31, 2021 $ 26,000 105,382,000 (77,183,000) 28,225,000 (355,000) 27,870,000
Ending Balance, shares at Mar. 31, 2021 25,983,676          
Beginning balance, value at Dec. 31, 2021 $ 27,000 106,666,000 (95,407,000) 11,286,000 (355,000) 10,931,000
Beginning Balance, shares at Dec. 31, 2021 26,902,763          
Exercise of employee options 4,000 4,000 4,000
Exercise of employee options, shares   89,986          
Vesting of RSUs $ 1,000 (1,000)
Vesting of RSUs, shares   135,000          
Shares withheld related to net share settlement of equity awards $ (1,000) (776,000) (777,000) (777,000)
Shares withheld related to net share settlement of equity awards, shares   (96,622)          
Stock-based compensation expense 2,016,000 2,016,000 2,016,000
Net loss (2,438,000) (2,438,000) (2,438,000)
Ending balance, value at Mar. 31, 2022 $ 27,000 $ 107,909,000 $ (97,845,000) $ 10,091,000 $ (355,000) $ 9,736,000
Ending Balance, shares at Mar. 31, 2022 27,031,127